Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Definium Therapeutics, Inc. (DFTX)

NASDAQ

$37.21

$+0.10

(+0.27%)

Pre-Market

Definium Therapeutics, Inc. (DFTX) Live Price Chart

Last updated: ⁦2026-09-16 09:06:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Definium Therapeutics, Inc. (DFTX) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $37.21, with a market capitalisation of $5.41B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.62 to $49.70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.41B
Open	$37.10
Day's High	$49.70
Day's Low	$14.62
Previous Close	$36.82
Volume	695.00
Average Volume	2.96M
P/E Ratio	--
52-Week High	$49.70
52-Week Low	$14.62
Dividend Yield	--
Earnings Date	--

Definium Therapeutics, Inc. (DFTX) Pre-Market Stock Price

Definium Therapeutics, Inc. (DFTX) is trading at $37.21 in pre-market trading as of 2026-09-16 08:44:00, up 1.05% ($0.38) from the previous close of $36.82

Pre-market trading shows how investors are pricing DFTX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Definium Therapeutics, Inc. (DFTX) 7-Day Stock Price Change

Over the past seven days, Definium Therapeutics, Inc. (DFTX) moved from $38.09 to $37.21, representing a decline of 2.32% ($0.89).

The stock traded between $36.78 and $43.77 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 2.70 million shares, up versus the previous seven-day period, indicating higher trading activity.

DFTX 52-Week Price Position

Position in Range: 64.4%

52W Low$14.62

52W High$49.70

DFTX is currently trading at $37.21, placing it 64.4% of the way from its 52-week low of $14.62 to its 52-week high of $49.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Definium Therapeutics, Inc. (DFTX)?

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Definium Therapeutics, Inc. Information

Industry	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees	106
Exchange	NASDAQ
Company Website	https://www.definiumtx.com

How to Buy Definium Therapeutics, Inc. (DFTX) Stock on MEXC

Eligible investors can buy real shares of Definium Therapeutics, Inc. (DFTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DFTX and Place Your Order

Open the RealStocks trading page and search for DFTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Definium Therapeutics, Inc. (DFTX) stock price today?

Definium Therapeutics, Inc. (DFTX) is currently trading at $ 37.21, up 1.05% ($0.38) from the previous close of $ 36.82. Intraday prices update in real time during regular trading hours.

2.Is DFTX stock going up or down today?

As of 2026-09-16 08:44:00, DFTX is trading at $ 37.21, up 1.05% ($0.38) from its previous close of $ 36.82. The stock has traded between $ 14.62 and $ 49.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is DFTX pre-market price?

As of 2026-09-16 08:44:00, DFTX is trading at $ 37.21 in pre-market trading, up 1.05% ($0.38) from the previous close of $ 36.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DFTX after-hours price?

As of 2026-09-16 08:44:00, DFTX is trading at $ 37.10 in after-hours trading, up 0.76% ($0.28) from the regular-session close of $ 36.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DFTX stock trading now?

DFTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DFTX sit relative to its 52-week high and low?

Over the past 52 weeks, DFTX has traded between a low of $ 14.62 and a high of $ 49.70. At $ 37.21, the stock is positioned 64.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Definium Therapeutics, Inc. in?

Definium Therapeutics, Inc. (DFTX) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Definium Therapeutics, Inc.'s market capitalisation and where is it listed?

Definium Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 5.41B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DFTX valued in terms of P/E ratio and EPS?

DFTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.63. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Definium Therapeutics, Inc. pay a dividend?

Definium Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.